Elderly long-term survivors in the Nordic phase II study with first-line maintenance temozolomide for primary central nervous system lymphoma: a 10-year follow-up

Haematologica. 2024 Mar 28. doi: 10.3324/haematol.2024.285207. Online ahead of print.ABSTRACTNot available.PMID:38546689 | DOI:10.3324/haematol.2024.285207
Source: Haematologica - Category: Hematology Authors: Source Type: research